SHUKRA PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of SHUKRA PHARMACEUTICALS have increased by 74.01% YoY .
The Earnings Per Share (EPS) of SHUKRA PHARMACEUTICALS has increased by 127.27 % YoY. |
||
SHUKRA PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 524632]
| Standalone | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹57 Cr | ₹33 Cr | ₹75 Cr | ₹59 Cr | ₹20 Cr |
| Expenses | ₹28 Cr | ₹20 Cr | ₹55 Cr | ₹53 Cr | ₹18 Cr |
| Operating Profit (Excl OI) | ₹29 Cr | ₹13 Cr | ₹19 Cr | ₹5.36 Cr | ₹2.89 Cr |
| Other Income | ₹4.59 Cr | ₹4.21 Cr | ₹2.82 Cr | ₹1.20 Cr | ₹0.08 Cr |
| Interest | ₹1.15 Cr | ₹0.60 Cr | ₹0.29 Cr | ₹0.28 Cr | ₹0.29 Cr |
| Depreciation | ₹3.44 Cr | ₹3.01 Cr | ₹2.05 Cr | ₹1.84 Cr | ₹1.66 Cr |
| Profit Before Tax | ₹29 Cr | ₹13 Cr | ₹20 Cr | ₹4.44 Cr | ₹1.02 Cr |
| Profit After Tax | ₹22 Cr | ₹9.58 Cr | ₹19 Cr | ₹4.41 Cr | ₹0.75 Cr |
| Earnings Per Share (Rs) | ₹0.50 | ₹0.22 | ₹16.94 | ₹11.26 | ₹4.79 |
| PAT Margin (%) | 38.88 | 29.38 | 24.86 | 7.49 | 3.66 |
| ROE(%) | 29.94 | 15.90 | 44.70 | 21.16 | 4.70 |
| ROCE(%) | 36.98 | 21.80 | 44.24 | 18.85 | 5.79 |
| Total Debt/Equity(x) | 0.06 | 0.07 | 0.05 | 0.20 | 0.21 |
Key Financials |
||
| Market Cap | : | ₹ 2,954.1 Cr |
| Revenue (TTM) | : | ₹ 74.8 Cr |
| Net Profit(TTM) | : | ₹ 36.0 Cr |
| EPS (TTM) | : | ₹ 0.8 |
| P/E (TTM) | : | 82.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SHUKRA PHARMACEUTICALS | -0.3% | 20.8% | 102.5% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.2% | -4.1% | 5.5% |
| DIVIS LABORATORIES | -3.1% | -1.6% | 47.3% |
| TORRENT PHARMACEUTICALS | -1.2% | -5% | 29.4% |
| CIPLA | 2.3% | -2% | -13.2% |
| DR REDDYS LABORATORIES | 2.2% | 6.2% | -2.5% |
| MANKIND PHARMA | -0.6% | 2.9% | -6% |
| LUPIN | -0% | -4.7% | -0.1% |
| ZYDUS LIFESCIENCES | 2.3% | 3.8% | 12.9% |
SHUKRA PHARMACEUTICALS Revenues
[BOM: 524632]
| Y-o-Y | 74.01 % |
| 5 Yr CAGR | 28.99 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹57 Cr | 74.01 | |
| Mar2025 | ₹33 Cr | -56.30 | |
| Mar2024 | ₹75 Cr | 26.75 | |
| Mar2023 | ₹59 Cr | 187.19 | |
| Mar2022 | ₹20 Cr | - | |
SHUKRA PHARMACEUTICALS Operating Profit
[BOM: 524632]
| Y-o-Y | 126.12 % |
| 5 Yr CAGR | 77.71 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹29 Cr | 126.12 | |
| Mar2025 | ₹13 Cr | -34.39 | |
| Mar2024 | ₹19 Cr | 261.79 | |
| Mar2023 | ₹5.36 Cr | 85.83 | |
| Mar2022 | ₹2.89 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 29.95 % |
| 5 Yr CAGR | 37.77 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 50.76% | 29.95 | |
| Mar2025 | 39.06% | 50.12 | |
| Mar2024 | 26.02% | 185.31 | |
| Mar2023 | 9.12% | -35.27 | |
| Mar2022 | 14.09% | - | |
SHUKRA PHARMACEUTICALS Profit After Tax
[BOM: 524632]
| Y-o-Y | 130.27 % |
| 5 Yr CAGR | 132.77 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹22 Cr | 130.27 | |
| Mar2025 | ₹9.58 Cr | -48.35 | |
| Mar2024 | ₹19 Cr | 320.63 | |
| Mar2023 | ₹4.41 Cr | 486.82 | |
| Mar2022 | ₹0.75 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 32.33 % |
| 5 Yr CAGR | 80.53 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 38.88 % | 32.33 | |
| Mar2025 | 29.38 % | 18.18 | |
| Mar2024 | 24.86 % | 231.91 | |
| Mar2023 | 7.49 % | 104.64 | |
| Mar2022 | 3.66 % | - | |
SHUKRA PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 524632]
| Y-o-Y | 127.27 % |
| 5 Yr CAGR | -43.16 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹0.50 | 127.27 | |
| Mar2025 | ₹0.22 | -98.70 | |
| Mar2024 | ₹17 | 50.44 | |
| Mar2023 | ₹11 | 135.07 | |
| Mar2022 | ₹4.79 | - | |
SHUKRA PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 524632]
| Y-o-Y | 69.63 % |
| 5 Yr CAGR | 58.97 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 36.98% | 69.63 | |
| Mar2025 | 21.8% | -50.72 | |
| Mar2024 | 44.24% | 134.69 | |
| Mar2023 | 18.85% | 225.56 | |
| Mar2022 | 5.79% | - | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹66.8 |
| Current MarketCap | : | ₹ 2,954.1 Cr |
| Updated EOD on | : | Oct 15,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | -0.3% |
20.8% |
102.5% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
SHUKRA PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | -0.4% | -5.7% | 10.1% |
You may also like the below Video Courses
FAQ about SHUKRA PHARMACEUTICALS Financials
How the annual revenues of SHUKRA PHARMACEUTICALS have changed ?
The Revenues of SHUKRA PHARMACEUTICALS have increased by 74.01% YoY .
How the Earnings per Share (EPS) of SHUKRA PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of SHUKRA PHARMACEUTICALS has increased by 127.27 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs